Ticagrelor is Not Superior to Clopidogrel in Patients With Acute Coronary Syndromes Undergoing PCI: A Report from Swedish Coronary Angiography and Angioplasty Registry

BACKGROUND: Ticagrelor reduces ischaemic end points in acute coronary syndromes. However, outcomes of ticagrelor versus clopidogrel in real‐world patients with acute coronary syndromes treated with percutaneous coronary intervention (PCI) remain unclear. We sought to examine whether treatment with t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Am Heart Assoc
Auteurs principaux: Völz, Sebastian, Petursson, Petur, Odenstedt, Jacob, Ioanes, Dan, Haraldsson, Inger, Angerås, Oskar, Dworeck, Christian, Hirlekar, Geir, Myredal, Anna, Albertsson, Per, Råmunddal, Truls, Redfors, Björn, Omerovic, Elmir
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7660716/
https://ncbi.nlm.nih.gov/pubmed/32662350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.119.015990
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires